ArticleOncoscience2014

Retaining the long-survive capacity of Circulating Tumor Cells (CTCs) followed by xeno-transplantation: not only from metastatic cancer of the breast but also of prostate cancer patients.

Elisabetta Rossi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.